Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
1.785
-0.015 (-0.83%)
At close: Jun 26, 2026, 4:00 PM EDT
1.800
+0.015 (0.84%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $70.49 million as of June 26, 2026. Its market cap has increased by 24.73% in one year.
Market Cap
70.49M
Enterprise Value
-13.78M
1-Year Change
24.73%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $70.49M, a decrease of -85.56%. That is a compound annual growth rate of -32.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 70.49M | -38.09% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 88.38M |
| Outset Medical | 85.09M |
| Rapid Micro Biosystems | 84.01M |
| LENSAR | 74.32M |
| SANUWAVE Health | 65.61M |
| Nano-X Imaging | 61.20M |
| electroCore | 59.65M |
| Xtant Medical Holdings | 59.12M |